Browsing Tag
Takeda Pharmaceutical Company
5 posts
AVT80 joins FDA review as Alvotech and Teva target both major Entyvio delivery formats
FDA accepts Alvotech’s AVT80 filing, expanding its Entyvio biosimilar strategy across subcutaneous and intravenous treatment with Teva.
Harmony’s next growth engine takes shape as BP-205 clears its first clinical test
BP-205 shows a 25-hour half-life as Harmony uses record WAKIX revenue to fund its next neuroscience growth engine amid rising orexin competition
Takeda’s TAK-755 shows potential in Phase 3 trial for cTTP prophylaxis
Takeda Pharmaceutical Company has revealed promising interim results from its global Phase 3 trial of TAK-755, a recombinant…
Takeda’s HYQVIA reduces CIDP relapse rates, Phase 3 trial reveals
Takeda Pharmaceutical Company has disclosed successful outcomes from its critical Phase 3 ADVANCE-CIDP 1 trial, focused on evaluating…
Takeda Pharmaceutical set to acquire TiGenix for €520m, enhancing gastroenterology and specialty care offerings
Japanese pharmaceutical giant Takeda Pharmaceutical has announced a proposal to acquire TiGenix, a Belgium-based cell therapy company, for…